WLF Appeal Could Receive Hearing By Spring 2000 Under FDA Expedited Plan
Executive Summary
The Washington Legal Foundation will challenge FDA's request for an expedited appeal to D.C. District Court Judge Royce Lamberth's July 28 ruling invalidating the off-label dissemination provisions of the FDA Modernization Act, WLF Chief Counsel Richard Samp told a Food & Drug Law Institute conference in Bethesda, Md. Sept. 13.
You may also be interested in...
WLF Ruling Offers No Viable Alternatives For Encouraging sNDAs - FDA Appeal
The ruling overturning FDA's regulation of off-label reprint dissemination offers no viable alternatives for encouraging companies to file supplemental new drug applications, FDA's appeal of Washington Legal Foundation v. Henney argues.
WLF Ruling Offers No Viable Alternatives For Encouraging sNDAs - FDA Appeal
The ruling overturning FDA's regulation of off-label reprint dissemination offers no viable alternatives for encouraging companies to file supplemental new drug applications, FDA's appeal of Washington Legal Foundation v. Henney argues.
Pharmacoeconomic Promotion May Change Less Than Expected - Perfetto
The healthcare economic claim provisions of the FDA Modernization Act may not change the pharmacoeconomic promotion environment as much as had initially been anticipated, QualityMetric Exec VP Eleanor Perfetto, PhD, reported to a Pharmaceutical Education and Research Institute meeting in Baltimore, Md. Sept. 30.